Details of the Drug Formulaction

General Information of Drug Formulation (ID: F22228)

• Formulation Name: Venlafaxine 37.5 mg capsule
• Company: Aphena Pharma Solutions-Tennessee; Aurobindo Pharma; Avera McKennan Hospital; Clinical Solutions Wholesale; Kaiser Foundation Hospitals; Lucid Pharma; RemedyRepack

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Venlafaxine	(DMR6QH0)	Anxiety disorder	6B00-6B0Z	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Eisenoxyd	(E00585)	56841934	Colorant
Ferrosoferric oxide	(E00231)	14789	Colorant
Saccharose	(E00091)	5988	Binding agent; Coating agent; Cryoprotectant; Diluent; Flavoring agent; Suspending agent; Viscosity-controlling agent
Sodium lauryl sulfate	(E00464)	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent